|November 21, 2022||
Registration Statement Nos. 333-236659 and 333-236659-01; Rule 424(b)(2)
Investing in the notes involves a number of risks. See “Risk Factors” beginning on page S-2 of the accompanying prospectus supplement, “Risk Factors” beginning on page PS-12 of the accompanying product supplement, “Risk Factors” beginning on page US-5 of the accompanying underlying supplement and “Selected Risk Considerations” beginning on page PS-6 of the pricing supplement.
Neither the Securities and Exchange Commission (the “SEC”) nor any state securities commission has approved or disapproved of the notes or passed upon the accuracy or the adequacy of this amendment, the pricing supplement or the accompanying product supplement, underlying supplement, prospectus supplement and prospectus. Any representation to the contrary is a criminal offense.
The notes are not bank deposits, are not insured by the Federal Deposit Insurance Corporation or any other governmental agency and are not obligations of, or guaranteed by, a bank
You should read this amendment together with the pricing supplement and the related product supplement, underlying supplement, prospectus supplement and prospectus, each of which can be accessed via the hyperlinks below. Please also see “Additional Terms Specific to the Notes” in the pricing supplement.
Pricing supplement dated October 31, 2022:
no. 4-II dated November 4, 2020:
supplement no. 6-III dated August 31, 2021:
Prospectus supplement and prospectus,
each dated April 8, 2020:
Amendment no. 1 to pricing supplement dated October 31, 2022 to product supplement no. 4-II dated November 4, 2020, underlying supplement no. 6-III dated August 31, 2021 and the prospectus and prospectus supplement, each dated April 8, 2020